Attachment 7 - Utilization of Cloud Service Provider (CSP) Migration Rebates.pdf
PDF 89 KB Posted
- Attached to
- CANCELLATION - The Food and Drug Administration Enterprise IT Application Development (EAD) BPA
- Solicitation number
- FDA-RFI-75F40124Q00156
About this file
This document is an attachment to a Blanket Purchase Agreement (BPA) Statement of Work (SOW) regarding the utilization of Cloud Service Provider (CSP) Migration Rebates. The key details are:
The contractor must notify the Contracting Officer's Representative (COR) and Contracting Officer (CO) within 10 business days of award if it intends to apply/utilize the Amazon Web Services (AWS) Migration Acceleration Program (MAP) or similar programs of other CSPs to host any business applications developed under this contract that will reside within the FDA GovCloud environment. The contractor must notify the COR and CO of the estimated amount and timelines for the rebates/credits received from the CSP program. The contractor must reimburse the FDA for all rebates/credits received, which can be used to acquire additional services, reduce the contract value, directly reimburse the FDA, provide service credits, or other approaches agreed upon. The FDA prefers to apply any discount or incentive as a service credit to its CSP consumption bill. The contractor is responsible for complying with the CSP program terms and conditions and promptly notifying the FDA of any changes. The contractor must keep the COR and CO informed of all steps and obtain their approvals.
View the file
Other files
Show all 14
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
BPA SOW Attachment: Utilization of Cloud Service Provider (CSP) Migration Rebates
The Contractor shall notify the Contracting Officer’s Representative (COR) and Contracting Officer (CO) within 10 business days from date of award if the Contractor intends to apply/utilize Amazon Web Services (AWS) Migration Acceleration Program (MAP) or similar programs of other CSPs to host any business application developed under this contract that will reside within FDA GovCloud environment. FDA acknowledges that the AWS MAP Program or similar programs has sole discretion of accepting or rejecting any business application developed under this contract into the AWS MAP Program or similar programs and the amount of the incentive/credit that the Food Drug Administration (FDA) shall receive.
The Contractor shall notify the COR and CO the estimated amount of AWS MAP Program or similar program incentives/credits and timelines that the Contractor shall receive in the following areas once they become known:
Step 1: Assess Your Readiness Step 2: Mobilize Your Resources Step 3: Migrate and Modernize Your Workloads
The Contractor shall reimburse FDA for all incentives/credit intended to facilitate and expediate the migration of FDA business applications that the Contractor receives from the AWS MAP Program or similar programs in the steps stated above. Incentives/credits shall be used to (1) acquire additional development and/operational services; (2) reduce the total value of the contract; (3) directly reimburse FDA; (4) provide service credit to FDA direct FDA AWS invoice, or (5) other incentive/credits approaches agreed to by the FDA and the Contractor. The approach chosen shall be executed via contract modification. The FDA prefers to apply any discount or incentive from CSP as a service credit to the FDA CSP consumption bill. In case of service credit, the Contractor shall work in a timely manner to provide required documents to FDA and FDA CSP Contractor to apply for the service credit.
The Contractor shall be responsible for complying with all of AWS MAP Program or similar program terms and conditions, including any changes associated with the incentives/credits that shall be received by FDA. The Contractor shall promptly notify the FDA CO and COR of any changes to the terms and conditions of the AWS MAP Incentive program or similar program that may impact FDA incentives/credits.
The Contractor shall ensure that all information and documentation related to CSP Program and the use of credits is accurate, complete, and up to date. The Contractor shall be responsible for any costs associated with applying for and obtaining the CSPCSP Program incentive/credits. The Contractor shall keep the COR and CO informed about all the steps and obtain their approvals.
File details come from the government source that posted it. Updated .